Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.

Thomsen HS, Morcos SK.

Br J Radiol. 2003 Aug;76(908):513-8. Review.

PMID:
12893691
2.

How to avoid CIN: guidelines from the European Society of Urogenital Radiology.

Thomsen HS.

Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i18-22. Review.

PMID:
15705944
3.

European Society of Urogenital Radiology guidelines on administering contrast media.

Morcos SK, Thomsen HS; European Society of Urogenital Radiology.

Abdom Imaging. 2003 Mar-Apr;28(2):187-90.

PMID:
12592465
4.
5.

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almén T, Aspelin P, Bellin MF, Clement O, Heinz-Peer G; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR).

Eur Radiol. 2011 Dec;21(12):2527-41. doi: 10.1007/s00330-011-2225-0. Epub 2011 Aug 25. Review.

PMID:
21866433
6.

[Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media].

Kuefner MA, Heinrich M, Bautz W, Uder M.

Rontgenpraxis. 2008;56(6):199-206. Review. German.

PMID:
19294866
7.

Theophylline option for attenuating contrast media-induced nephrotoxicity in patients on metformin.

Nolan DB.

Am J Health Syst Pharm. 1997 Mar 1;54(5):587-8. No abstract available.

PMID:
9066873
8.
9.

Water for contrast-induced nephropathy? A thirst for knowledge.

Pate GE, Webb JG.

J Invasive Cardiol. 2003 Dec;15(12):703-5. No abstract available.

PMID:
14660822
10.

European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media.

Thomsen HS.

Eur J Radiol. 2006 Dec;60(3):307-13. Epub 2006 Sep 11.

PMID:
16965884
12.

Contrast-induced nephropathy--a review of current literature and guidelines.

Maliborski A, Zukowski P, Nowicki G, Bogusławska R.

Med Sci Monit. 2011 Sep;17(9):RA199-204. Review.

13.

Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines.

Thomsen HS, Morcos SK.

Eur Radiol. 2006 Aug;16(8):1835-40. Epub 2006 May 4. Review.

PMID:
16673094
14.

Preventing nephropathy induced by contrast medium.

Gross JL, Friedman R, Silveiro SP.

N Engl J Med. 2006 Apr 27;354(17):1853-5; author reply 1853-5. No abstract available.

15.

[Contrast medica nephropathy. Better understanding of risk markers and follow up needed].

Sterner G, Hellström M, Lagerqvist B, Aspelin P, Nyman U.

Lakartidningen. 2009 Jun 24-Jul 7;106(26-27):1737-42. Swedish. No abstract available.

PMID:
19731735
16.

Serum creatinine measurements: evaluation of a questionnaire according to the ESUR guidelines.

Zähringer C, Potthast S, Tyndall AJ, Bongartz G, Hohmann J.

Acta Radiol. 2015 May;56(5):628-34. doi: 10.1177/0284185114533244. Epub 2014 May 27.

PMID:
24867223
17.

Metformin, contrast media, and theophylline.

Quasny H.

Am J Health Syst Pharm. 1997 Sep 1;54(17):2007-8. No abstract available.

PMID:
9290904
18.

[Iodinated contrast agents used in Radiology].

Ramírez Ribelles C, Sánchez Fuster MA, Pamies Guilabert J.

Radiologia. 2014 Jun;56 Suppl 1:12-20. doi: 10.1016/j.rx.2014.06.002. Epub 2014 Sep 27. Spanish.

19.

The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.

Friedewald VE, Goldfarb S, Laskey WK, Vetrovec GW, Roberts WC.

Am J Cardiol. 2011 Jun 15;107(12):1848-55. doi: 10.1016/j.amjcard.2010.10.001. No abstract available.

PMID:
21640219
20.

Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.

Tsushima Y, Ishiguchi T, Murakami T, Hayashi H, Hayakawa K, Fukuda K, Korogi Y, Sugimoto H, Takehara Y, Narumi Y, Arai Y, Kuwatsuru R, Yoshimitsu K, Awai K, Kanematsu M, Takagi R.

Jpn J Radiol. 2016 Feb;34(2):130-9. doi: 10.1007/s11604-015-0505-3. Epub 2015 Dec 10.

PMID:
26662468

Supplemental Content

Support Center